Objective : Routine use of prophylactic antiepileptic drugs (AED) has been debated. We retrospectively evaluated the effects of prophylactic AED on clinical outcomes in patients with a good clinical grade suffering from aneurysmal subarachnoid hemorrhage (aSAH).
INTRODUCTION

MATERIALS AND METHODS
This retrospective study was approved by our institutional review board, and the requirement for in- 
DISCUSSION
In the current study, seizure did not occur in aSAH for worse outcomes after three months of follow-up, as well as increased risk for vasospasm, neurological deterioration, cerebral infarction, and elevated temperature during hospitalization. 18) In the current study, the clinical outcomes at discharge and after six months of follow-up were not statistically different between the two groups (p = 0.607 and 0.178, respectively). At discharge, 86.4% of patients in the AED group showed a favorable outcome, but there was one death due to pneumonia. In the no AED group, 90.0% of patients showed favorable outcomes without mortality. However, after six months of follow-up, favorable outcomes of patients in the no AED group showed a slight increase to 95.0% and poor outcomes decreased to 5.0%.
In clinical practice, AED usage for patients with aSAH is generally accepted for prevention of seizure episodes. According to the current guidelines, 
CONCLUSION
No difference in clinical outcomes and systemic complications at discharge and after six months of follow-up was observed between the two groups. However, favorable outcomes in the no AED group showed a slight increase after six months. Our findings suggest that discontinuation of the current practice of prophy-lactic AED use might be recommended in patients with a good clinical grade.
